A

Animol Discovery, Inc.

17 employees

We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
DNA-encoded Chemical Libraries
Therapeutics
Veterinary Medicine
Animal Health
Antiparasitics
Drug Discovery
Machine Learning

Date founded

2019

Funding rounds raised

Total raised

$34M

from 4 investors over 4 rounds

A

Animol Discovery, Inc. raised $34M on July 28, 2022

Investors: Novalis LifeSciences LLC, Anterra Capital and Finistere Ventures LLC

A

Animol Discovery, Inc. raised $6M on January 1, 2020

Investors: Anterra Capital

FAQ